His Internal medicine study often links to related topics such as Prospective cohort study. Borrowing concepts from Urology, he weaves in ideas under Surgery. His work blends Urology and Surgery studies together. His multidisciplinary approach integrates Cancer and Survival rate in his work. He performs integrative study on Survival rate and Cancer. His Oncology study frequently draws connections between related disciplines such as Overall survival. The study of Overall survival is intertwined with the study of Oncology in a number of ways. His Radiology study frequently draws parallels with other fields, such as Soft tissue. Many of his studies involve connections with topics such as Radiology and Soft tissue.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Cancer, Randomized controlled trial, Confidence interval, Lung cancer and Cohort. He performs multidisciplinary study in the fields of Cancer and Oncology via his papers. His Lung cancer research extends to Oncology, which is thematically connected. His research is interdisciplinary, bridging the disciplines of Live birth and Genetics. With his scientific publications, his incorporates both Pregnancy and Gestational age. His Genetics research extends to Gestational age, which is thematically connected. He undertakes interdisciplinary study in the fields of Obstetrics and Gynecology through his research. Harry J.M. Groen undertakes multidisciplinary studies into Gynecology and Obstetrics in his work. By researching both Infertility and Pregnancy, Harry J.M. Groen produces research that crosses academic boundaries.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran.
Lancet Oncology (2015)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George.
Nature Genetics (2012)
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Harry J. de Koning;Carlijn M. van der Aalst;Pim A. de Jong;Ernst T. Scholten.
The New England Journal of Medicine (2020)
Multiple common variants for celiac disease influencing immune gene expression
Patrick C. A. Dubois;Gosia Trynka;Lude Franke;Lude Franke;Karen A. Hunt.
Nature Genetics (2010)
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss;Martin L. Sos;Danila Seidel;Martin Peifer.
Science Translational Medicine (2010)
Management of lung nodules detected by volume CT scanning
Rob J van Klaveren;Matthijs Oudkerk;Mathias Prokop;Ernst T Scholten.
The New England Journal of Medicine (2009)
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
David Planchard;Egbert F Smit;Harry J M Groen;Julien Mazieres.
Lancet Oncology (2016)
An open-label phase 2 trial of dabrafenib plus trametinib in patients with previously treated BRAF V600E–mutant metastatic non-small cell lung cancer
David Planchard;Benjamin Besse;Harry J M Groen;Pierre-Jean Souquet.
Lancet Oncology (2016)
A genomics-based classification of human lung tumors
Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer.
Science Translational Medicine (2013)
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
Peter S. Hammerman;Martin L. Sos;Alex H. Ramos;Chunxiao Xu.
Cancer Discovery (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: